Publicity for sports supplement programs
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplement industry "is doing a horrible job" of getting information out about its self-regulatory efforts, notes Jon Benninger at the Food and Drug Law Institute's dietary supplement emerging issues and trends conference Jan. 29 in Washington. Benninger, director of business development for Virgo Publishing, recounts how the CEO of U.S. Track and Field had discouraged use of all supplements by the group's athletes and was unaware of programs that screen supplement products tailored to professional athletes. Such programs include the Athletic Banned Substances Certification Program and a separate certification initiative specifically for National Football League players, both run by NSF International (1"The Tan Sheet" Jan. 21, 2008, p. 7). While such programs are admirable, Benninger says it remains up to industry to publicize the efforts
You may also be interested in...
NSF Expands Sports Product Testing, Appoints GM At “Crucial Time”
NSF International appointed Edward Wyszumiala Jan. 14 to head the organization's supplement programs as it expands its testing of sports nutrition products for banned substances in response to growing concern about adulterated products
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.